OUR CONTRACT PHARMACEUTICAL SERVICES

Company Overview

PHARMACEUTICAL FORMULATION DEVELOPMENT

Widely recognised as leading experts in all aspects of pharmaceutical formulation development and dosage form optimisation.

Read MoreWatch Now

Quay Pharma is widely recognised as leading experts in all aspects of pharmaceutical development and dosage form optimisation for a wide range of product types, including those that have poor solubility or bioavailability.

We also have knowledge and expertise in the formulation development of modified or targeted release within the body. A comprehensive selection of supporting technologies underpins our professional expertise, and all prototype formulations undergo extensive screening and stability evaluation in a non-GMP environment.

Once Quay Pharma has investigated the fundamental properties of a drug, we can prepare a formulation development strategy to bring it rapidly and effectively to First in Human (FIH) studies and on towards clinical use.

The formulations we create are designed to match our clients’ requirements and resources precisely. Significantly, they are provided royalty-free, so there is no commitment or limiting factor on any future development.

Our work is carried out on a purely fee-for-service basis, with our aim to provide the best formulation development and the best chance of clinical success. An extensive suite of formulation development services is offered at Quay Pharma.

Development Capabilities - Oral Dosage Forms

  • Immediate release and controlled release tablets
  • Multilayer tablets
  • Immediate release capsules
  • Oral multiparticulates such as beads, pellets and mini-tablets
  • Liquid and semi-solid filled capsules
  • Fast dispersible tablets
  • Coating of tablets, capsules and pellets
  • Micro-encapsulation using spray drying
  • Oral liquids and suspensions
  • Non-sterile, live bacteria for oral delivery

Other Dosage Forms Include:

  • Liquids and semi-solids for topical delivery, such as creams, ointments, lotions and gels
  • Parenteral formulations for early phase toxicity evaluation
  • Buccal delivery
  • Nasal sprays
  • Dental products
Your Dedicated Contacts
Maura McArdle
Head of Business Development
(Formulation Development)
Contact

Maura McArdle joined Quay as Head of Business Development for Europe in 2019. Maura’s appointment is to ensure continued focus on Quay’s core business, Pharmaceutical Development of small molecule compounds. With a degree in Chemical Engineering, Maura has over 20 years of business development experience into the Chemical and Pharmaceutical industries having previously worked for Almac, Brenntag and BASF.

Contact
Mike Frodsham
Chief Technical Officer
(CTO)
Contact

Mike has over 20 years’ experience in drug product development. For over 15 years he has been responsible for development activities at Quay Pharma. During this period Mike has overseen over 200 non-sterile development projects; predominantly taking NCE’s through to first in human studies and beyond. His background is in formulation science with a PhD in liquisolid dosage forms and is cited as an inventor on multiple oral formulation patents.

Contact
Our Pharmaceutical Services

Preclinical Formulation

Robust formulation development strategies tailored to the characteristics of each individual API.

Find Out More

Pharmaceutical Preformulation

Analysis of Active Pharmaceutical Ingredients (APIs), including those that present particular challenges.

Find Out More

Pharmaceutical Formulation Development

Dosage form optimisation for a wide range of product types including those that have poor solubility or bioavailability.

Find Out More

Analytical Services

Analytical specialists working alongside our formulation and manufacturing teams which provide expert advice.

Find Out More

Phase I Clinical Manufacturing

Early clinical formulations and clinical manufacturing of First in Human trials and clinical evaluations of your API.

Find Out More

Phase II & III Clinical Manufacturing

Fully equipped and accredited to manufacture a wide range of products for Phase II and small-scale Phase III trials.

Find Out More

Commercial Manufacture & Packaging

MHRA licensed to include commercial manufacture. Services include contract packaging and assembly...

Find Out More

Clinical Trial Supply

Complete range of clinical trial supply packaging for solid and liquid dosages. Despatched with full QP release certification.

Find Out More

Live Biotherapeutics Drug Delivery

One of the few companies licensed for the clinical manufacture of live biotherapeutics products.

Find Out More

Orphan Drugs

Perfectly equipped to deliver an Orphan Drug molecule from preclinical and formulation development to small scale commercialisation.

Find Out More

Specials Manufacturing

One of the limited number of contract manufacturers who hold an MRHA license for the manufacture and supply of ‘specials’.

Find Out More

Let's Talk Project Success

Talk directly to the Quay staff - Our dedicated team leaders are ready to listen and help with your project.

Contact Us